The Carrell-Krusen Abstract Selection Committee invites you to submit an abstract for presentation at the 44th Annual Carrell-Krusen Neuromuscular Symposium, to be held VIRTUALLY February 24-25, 2022.

PLEASE NOTE: Abstract submissions on this site are for consideration of content to be presented at a certified Continuing Medical Education Activity. Per the ACCME Standards of Commercial Support, employees of commercial supporters (i.e. pharmaceutical and/or medical device companies) are restricted from influencing the control of CME program content. As such, employees of commercial interests may not participate in authoring, co-authoring and/or presenting content that is certified for CME.



General Guidelines

  • Spell out all abbreviated terms at first use
  • Do not include a continuation page, illustrations, or tables
  • Cases will be discussed with the goal of identifying the diagnosis during the live presentation, as part of the learning activity. As such, the final diagnosis is to be omitted from the title and body of the abstract.
  • Do NOT exceed 300 words or use continuation pages, illustrations or tables. Please omit the diagnosis from the title and the body of the abstract.


  • Content addresses the identification, diagnosis, treatment and/or management of neuromuscular diseases.
  • Abstracts must report work not presented or published prior to the meeting
  • All authors must be listed in space provided (please include a good email address so that they can be easily contacted to complete a CME disclosure form)
  • Please see table below for presentation category, format and abstract submission content details

Please note that the Abstract Selection Committee may change the Abstract category based on the context of submissions, format options available in the schedule and overall goals of the conference. You will be notified of this change upon acceptance of submission.

Abstract CategoryPresentation FormatAbstract Content
Video Patient15 minute virtual presentation (patient assessments pre-recorded)Concise summary of history and physical exam, video demonstrating physical/neurologic findings, lab results, discussion of differential diagnosis and final diagnosis with management/treatment
Scientific/Case Series15 minute virtual presentationInclude purpose of study, methods, results and conclusions
Path-Rads and EP10 minute virtual presentationInclude brief clinical history/PE, results of electrodiagnostic and histologic studies, DNA analysis and conclusions.


(NOT certified for CME)

Electronic Poster file (PowerPoint or PDF)

Include purpose of study, methods, results and conclusions

Selection Criteria:

The abstract selection committee is committed to a rigorous, systematic process to identify presentations that will contribute to the overall goals of the symposium. As such, the evaluation and selection of abstracts will be based on:

  • Clarity of purpose/problem statement
  • Quality of research methods (if applicable)
  • Relevance to medical practice (applicability or advances knowledge in the field)


  • The First Author of accepted abstracts will be notified by email before December 22, 2021.
  • The time allowed for presentations from the platform and posters may vary according to the material presented and the needs of the session and will be determined at time of abstract acceptance.
  • Accepted abstracts will be printed in the Journal of Clinical Neuromuscular Disease.

A panel from the Abstract Selection Committee Awards will identify the best abstract presentations, which will be announced prior to the close of the symposium


  • It is the policy of ACCME that all persons in the position to control the content of an educational activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. A primary mechanism to resolve identified conflicts of interest is a content review that is prior to the activity.
  • Upon acceptance of the abstract, ALL authors will be emailed a link to complete an online Conflict of Interest Disclosure form.
  • All online disclosure forms must be completed no later than Tuesday, January 4, 2022. It is the responsibility of the First Author to ensure all disclosures are submitted by this deadline. Failure to provide this information may result in your abstract being removed from the program.


  • It is the speakers’ responsibility to register for the symposium. Abstract acceptance does not guarantee any type of registration discount.